Article Details
Retrieved on: 2024-11-30 16:53:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Analyst Vikram Purohit from Morgan Stanley maintained a Buy rating on Axsome Therapeutics (AXSM – Research Report) and keeping the price target .
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here